Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gynecologic 2Genitourinary 2Gastrointestinal 2Breast 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Lung Neoplasms 23Leukemia, Myeloid, Acute 23Neoplasm Metastasis 19Breast Neoplasms 19Pancreatic Neoplasms 16Multiple Myeloma 14Melanoma 13Prostatic Neoplasms 12Carcinoma, Renal Cell 12Carcinoma, Non-Small-Cell Lung 12Burkitt Lymphoma 12Lymphoma 11Colorectal Neoplasms 11Urinary Bladder Neoplasms 10Triple Negative Breast Neoplasms 10Squamous Cell Carcinoma of Head and Neck 8Ovarian Neoplasms 8Mouth Neoplasms 8Leukemia, Lymphocytic, Chronic, B-Cell 8Glioma 8Endometrial Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Oropharyngeal Neoplasms 7Myelodysplastic Syndromes 7Laryngeal Neoplasms 7Fallopian Tube Neoplasms 7Carcinoma, Hepatocellular 7Carcinoma 7Neuroblastoma 6Nasopharyngeal Carcinoma 6

Interventions

Fluorouracil 7Oxaliplatin 6Nivolumab 6pembrolizumab 5Leucovorin 5fludarabine 4Cyclophosphamide 4Capecitabine 4zimberelimab 3aldesleukin 3Trastuzumab 3Paclitaxel 3Docetaxel 3zanidatamab 2ulixertinib 2trastuzumab deruxtecan 2ipatasertib 2fludarabine phosphate 2atezolizumab 2Specimen Handling 2Ramucirumab 2Irinotecan 2zolbetuximab 1trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1trametinib 1tislelizumab 1sodium propionate 1sapanisertib 1relatlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Stomach Neoplasms × Specimen Handling × 30 days × Clear all
NCT02465060 2026-06-03

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
6,452 enrolled 1 FDA
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmPlasma cellThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Lung Neoplasms, Lymphoma, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT06995898 2026-06-01

The Vanguard Study: Testing a New Way to Screen for Cancer

National Cancer Institute (NCI)

Phase NA Recruiting
24,000 enrolled
BreastGastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡